One of the most hilarious rant I've read on HC. Provided the clinical trial updates are further positive then the pps will re-rate, IMU has enough fund to complete Ph1 clinical trial so how will PH "destroy" the company??? BP and FDA only care about clinical trial updates not PH or the management.
IMU Price at posting:
3.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)